Pharma

Your Article Summary

See Latest Articles

Mpex Pharmaceuticals Names Mark Wiggins Chief Business Officer
Mpex Pharmaceuticals, 04/21/09

Mpex Pharmaceuticals, Inc. announced that Mark Wiggins has joined the company as Chief Business Officer. Mr. Wiggins comes to Mpex from Biogen Idec, Inc. where he most recently served as Executive Vice President of Business Development, and was a member of the Executive Committee. At Mpex he will be focusing on commercial planning and business development activities related to the company's lead product, MP-376. MP-376 is an inhaled antibiotic which is being developed for use as a maintenance therapy for the prevention of exacerbations in cystic fibrosis (CF) and chronic obstructive pulmonary disease.

Today in Execs on the Move...keeping you current

Receive free subspecialty "5-minute updates" via email

Boston Scientific Announces Election of Nelda Connors to Its Board of Directors
Boston Scientific, 12/17/09

Sanofi-aventis Board of Directors of December 2009
Sanofi-aventis, 12/17/09

Bristol-Myers Squibb Announces Appointment of Charles Bancroft as Acting Chief Financial Officer
Bristol Myers-Squibb Company, 12/15/09

 See all of Execs on the Move